Skip to main content

Clinical Manifestations of and Laboratory Tests for Myocarditis and Fulminant Myocarditis

  • Chapter
  • First Online:
Fulminant Myocarditis

Abstract

Fulminant myocarditis is the most severe and special type of myocarditis, most patients with fulminant myocarditis have some some prodromal of pathogen infection and within few days have severe fatigue, poor appetite and may have a little diarrhea, chest comfort, chest pain or dizziness due to hypotension. Vital signs usually change, including hypotension or shock and fast heart rate, and heart sound markedly reduced and often hear third sound gallop. ECG usually has marked change such as low voltage and widened QRS wave and arrhythmias. Cardiac troponin I or T and NT-proBNP significantly elevated, which suggest acute myocardial injury. Timely cardiac echo can find diffuse hypokinesia of the heart LVEF reduce and change fast. Tests of level of plasma inflammatory factors is greatly helpful for diagnosis of fulminant myocarditis, especially soluble ST2 level elevation (>55ng/mL). What need to exclude in most is acute myocardial infarction (by coronary angiography), and next is stress cardiomyopathy. Timely clinical diagnosis is important for saving life. Endomyocardial biopsy and MRI should be performed for clear diagnosis. The key is “early identification, early diagnosis, early prediction and early treatment”.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Precision Medicine Group of Chinese Society of Cardiology, Chinese Journal of Cardiology Editorial Committee, Adult Fulminant Myocarditis Working Group. Chinese expert consensus on the diagnosis and treatment of adult fulminant myocarditis. Chin J Cardiol. 2017;45:742–52.

    Google Scholar 

  2. Wang Z, Wang Y, Lin H, Wang S, Cai X, Gao D. Early characteristics of fulminant myocarditis vs non-fulminant myocarditis: a meta-analysis. Medicine (Baltimore). 2019;98:e14697. https://doi.org/10.1097/MD.0000000000014697.

    Article  Google Scholar 

  3. Fairley SL, Herron B, Wilson CM, Roberts MJ. Acute fulminant necrotising lymphocytic myocarditis in a patient with mixed connective tissue disease: a rapid clinical response to immunosuppression. Ulster Med J. 2014;83:119–20.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Kwon OH, Kim MN, Kim SA, Seok HY, Park SM, Kim BJ, Kim CH, Shim WJ, Shim JS, Lee MG. Fulminant lymphocytic myocarditis associated with orbital myositis and diaphragmatic paralysis. Cardiovasc Pathol. 2016;25:55–8. https://doi.org/10.1016/j.carpath.2015.08.004.

    Article  PubMed  Google Scholar 

  5. Chen B, Zhong B, Wang W. Successful rescue of 1 case of fulminant myocarditis using extracorporeal membrane oxygenation technology. J Electrocardiol Circulation. 2020;39:86–8.

    CAS  Google Scholar 

  6. Wu Q, Jiang J, Xia X, et al. One case of fulminant myocarditis was successfully rescued. J Intern Intens Med. 2019;25:516–8.

    Google Scholar 

  7. Mcmullan DM. Expanding the availability of extracorporeal cardiopulmonary resuscitation. Pediatrics. 2013;131:e934–8. https://doi.org/10.1542/peds.2011-2371.

    Article  PubMed  Google Scholar 

  8. Yukiiri K, Mizushige K, Ueda T, Nanba T, Tanimoto K, Wada Y, Takagi Y, Ohmori K, Kohno M. Fulminant myocarditis in polymyositis. Jpn Circ J. 2001;65:991–3. https://doi.org/10.1253/jcj.65.991.

    Article  CAS  PubMed  Google Scholar 

  9. Xie J, Wen Y, Liu D, et al. A case of fulminant myocarditis resembling acute myocardial infarction. Chin J Arteriosclerosis. 2020;28:65–6.

    Google Scholar 

  10. Tagawa M, Nakamura Y, Okura Y, Nanba H, Kishi K, Akashi E, Ochiai Y, Asai Y, Chinushi M. Successful treatment of acute fulminant eosinophilic myocarditis in a patient with ulcerative colitis using steroid therapy and percutaneous cardiopulmonary support. Intern Med. 2019;58:1111–8. https://doi.org/10.2169/internalmedicine.1528-18.

    Article  PubMed  Google Scholar 

  11. Yonenaga A, Hasumi E, Fujiu K, Ushiku A, Hatano M, Ando J, Morita H, Watanabe M, Komuro I. Prognostic improvement of acute necrotizing eosinophilic myocarditis (ANEM) through a rapid pathological diagnosis and appropriate therapy. Int Heart J. 2018;59:641–6. https://doi.org/10.1536/ihj.17-308.

    Article  PubMed  Google Scholar 

  12. Moriwaki K, Dohi K, Omori T, Tanimura M, Sugiura E, Nakamori S, Sawai T, Imanaka-Yoshida K, Yamada N, Ito M. A survival case of fulminant right-side dominant eosinophilic myocarditis. Int Heart J. 2017;58:459–62. https://doi.org/10.1536/ihj.16-338.

    Article  PubMed  Google Scholar 

  13. Yamamoto M, Yoneyama F, Kato H, Ieda M. Mitral chordal rupture by Impella 5.0 in a patient with fulminant myocarditis and inflammation of mitral chordae. Eur Heart J. 2020;41:1943. https://doi.org/10.1093/eurheartj/ehz675.

    Article  PubMed  Google Scholar 

  14. Allen SF, Godley RW, Evron JM, Heider A, Nicklas JM, Thomas MP. Acute necrotizing eosinophilic myocarditis in a patient taking Garcinia cambogia extract successfully treated with high-dose corticosteroids. Can J Cardiol. 2014;30(1732):e13–5. https://doi.org/10.1016/j.cjca.2014.08.025.

    Article  Google Scholar 

  15. Long Y, Yao Z, Sun W, et al. Clinical analysis of 62 cases of adult fulminant myocarditis. Chin J Lab Diagnosis. 2020;24:218–21.

    Google Scholar 

  16. Zhao H, Liu W, Ren Y, et al. Analysis of influencing factors of death in adult patients with fulminant myocarditis during hospitalization. Chin Med. 2020;15:13–7.

    Google Scholar 

  17. Fukae S, Ashizawa N, Morikawa S, Yano K. A fatal case of fulminant myocarditis with human herpesvirus-6 infection. Intern Med. 2000;39:632–6. https://doi.org/10.2169/internalmedicine.39.632.

    Article  CAS  PubMed  Google Scholar 

  18. Ding J, Zhou S, Tan W, et al. Clinical diagnosis and treatment analysis of 10 cases of fulminant myocarditis in children. Chin Pediatr Integr Traditional Western Med. 2012;04:254–6.

    Google Scholar 

  19. Jia X, Zhang C. The role of cytokines in fulminant myocarditis. Zhejiang Medicine. 2019;41:614–7.

    Google Scholar 

  20. Zhu B, Nie Y. The effect of continuous blood purification on serum inflammatory cytokines and hemodynamics in patients with fulminant myocarditis. Chin J Integr Med on Cardio-/Cerebrovascuiar Dis. 2020;18:297–300.

    Google Scholar 

  21. Senderek T, Małecka B, Ząbek A, Rudnicka-Sosin L, Wierzbicki K, Przybyłowski P, Bednarek J, Lelakowski J. Fulminant heart failure due to giant cell myocarditis affecting the left ventricle. Postepy Kardiol Interwencyjnej. 2015;11:351–3. https://doi.org/10.5114/pwki.2015.55613.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dao Wen Wang .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wang, D.W. (2022). Clinical Manifestations of and Laboratory Tests for Myocarditis and Fulminant Myocarditis. In: Wang, D.W. (eds) Fulminant Myocarditis. Springer, Singapore. https://doi.org/10.1007/978-981-19-5759-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-981-19-5759-8_7

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-19-5758-1

  • Online ISBN: 978-981-19-5759-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics